Faculty, Staff and Student Publications
Publication Date
10-1-2024
Journal
Nature Reviews Urology
DOI
10.1038/s41585-024-00869-9
PMID
38627553
PMCID
PMC12067944
PubMedCentral® Posted Date
5-12-2025
PubMedCentral® Full Text Version
Author MSS
Abstract
Ferroptosis is a distinct form of regulated cell death that is predominantly driven by the build-up of intracellular iron and lipid peroxides. Ferroptosis suppression is widely accepted to contribute to the pathogenesis of several tumours including prostate cancer. Results from some studies reported that prostate cancer cells can be highly susceptible to ferroptosis inducers, providing potential for an interesting new avenue of therapeutic intervention for advanced prostate cancer. In this Perspective, we describe novel molecular underpinnings and metabolic drivers of ferroptosis, analyse the functions and mechanisms of ferroptosis in tumours, and highlight prostate cancer-specific susceptibilities to ferroptosis by connecting ferroptosis pathways to the distinctive metabolic reprogramming of prostate cancer cells. Leveraging these novel mechanistic insights could provide innovative therapeutic opportunities in which ferroptosis induction augments the efficacy of currently available prostate cancer treatment regimens, pending the elimination of major bottlenecks for the clinical translation of these treatment combinations, such as the development of clinical-grade inhibitors of the anti-ferroptotic enzymes as well as non-invasive biomarkers of ferroptosis. These biomarkers could be exploited for diagnostic imaging and treatment decision-making.
Keywords
Ferroptosis, Humans, Male, Prostatic Neoplasms, Biomarkers, Tumor
Published Open-Access
yes
Recommended Citation
Cao, Pham Hong Anh; Dominic, Abishai; Lujan, Fabiola Ester; et al., "Unlocking Ferroptosis in Prostate Cancer – the Road to Novel Therapies and Imaging Markers" (2024). Faculty, Staff and Student Publications. 4257.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4257
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Diseases Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons, Urology Commons